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Abstract
Background: The assessment of patients’ quality of life (QOL) is essential when evaluating the outcome of palliative
care; however, no instruments have been validated for measuring symptoms and QOL in patients receiving
palliative care in Chile. We aimed to investigate the content validity of the EORTC Quality of Life Questionnaire Core
15 Palliative Care (QLQ-C15-PAL), replicating the methods used previously to shorten the EORTC Quality of Life
Questionnaire Core 30 (QLQ-C30) for use among patients in palliative care.
Methods: This cross-sectional study was conducted from October to November 2017 in four palliative care services.
Patients with advanced cancer and health care professionals (HCPs) were invited to individual interviews to
determine the relevance, appropriateness and relative importance of the 30 items of the QLQ-C30 for evaluating
the outcome of palliative care, and whether relevant additional issues should be included.
Results: A total of 48 patients and 35 HCPs participated. The most important dimensions selected were pain,
physical functioning, sleeping difficulties, emotional functioning, nausea/vomiting, fatigue, social functioning, lack of
appetite, role functioning and constipation. Qualitative data identified important additional issues not covered by
the questionnaire such as satisfaction with care, emotions and psychological support, as well as linguistic issues in
the dyspnea and constipation items.
Conclusions: The EORTC QLQ-C15-PAL showed good content validity in the assessment of symptoms and QOL of
advanced cancer patients; therefore, we recommend the use of this questionnaire in palliative care in Chile.
Dyspnea and constipation items were revised by the EORTC group. More research is needed to add a social
dimension for a comprehensive assessment of patients’ QOL.
Keywords: EORTC QLQ-C15-PAL, Advanced cancer, Palliative care, Symptom assessment, Quality of life, Patient-
reported outcomes
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Background
Palliative care aims to improve the quality of life (QOL)
of patients through the early detection and treatment of
their symptoms [1]. Thus, the assessment of patients’
QOL is essential when evaluating the outcome of pallia-
tive care. Nevertheless, assessment of QOL may be diffi-
cult in patients with advanced cancer due to the number
and severity of symptoms they experience. To reduce
the burden on patients, patient-reported outcomes
(PROs) instruments in palliative care should be brief,
cover the main symptoms and problems, and at the
same time avoid content of limited relevance.
The European Organization for Research and Treat-
ment of Cancer (EORTC) Quality of Life Questionnaire
Core 15 Palliative Care (QLQ-C15-PAL) is an abbrevi-
ated 15-item version of the EORTC Quality of Life
Questionnaire Core 30 (QLQ-C30), which is one of the
most widely used, validated, translated and published in-
struments for assessing symptoms and QOL in cancer
patients [2]. The QLQ-C15-PAL contains the items of
the QLQ-C30 which were identified as the most import-
ant for palliative care, based on interviews with health
care professionals and patients [3], and on statistical
analyses using item response theory [4, 5]. This develop-
ment process secures that studies may compare their re-
sults obtained from the QLQ C15-PAL with studies
using the original QLQ-C30 questionnaire [3]. In
addition, the QLQ-C15-PAL has been successfully vali-
dated and translated in several countries [6–14], includ-
ing Spanish-speaking countries [15, 16].
The Chilean-Spanish version of the QLQ-C30 and
some modules have been validated before [17, 18]. A few
studies have used the QLQ-C30 to evaluate patients’
QOL in oncology research [19–22], but no instruments
have been validated for measuring symptoms and QOL
in patients receiving palliative care in Chile. When the
QLQ-C15-PAL was developed, its content validity was
evaluated by health care professionals and patients from
six European countries [3]. However, because of differ-
ences between these European countries and Chile in
their health care systems, including how palliative care is
organized, and the availability of palliative care services,
it would be relevant to investigate the content validity of
the QLQ-C15-PAL in Chilean population. In Chile most
palliative care services are in the public health care sys-
tem, but some services are fully private. Although Chile
has the highest number of palliative care services in
Latin America [23], Chile still has a fewer number of
palliative services compared to the Western European
countries. In 2013, the ratio of services to the population
in Chile was 1: 808,000, which is lower compared to the
six European countries with a ratio of services to the
population between 1: 48,000 (in the United Kingdom),
and 1: 122,000 (in Denmark) [24]. Therefore, we aimed
to investigate the content validity of the QLQ-C15-PAL
questionnaire with patients and health care professionals
from palliative care services in Chile, replicating the
methods used previously to shorten the items of the
QLQ-C30 among European patients in palliative care
[3].
Methods
Patients and health care professionals
This cross-sectional study was conducted from October
to November 2017 with participants from the palliative
care services of four public hospitals in Santiago in
Chile. We planned to recruit at least 10 patients and 10
heath care professionals (HCPs) from each palliative care
service.
Outpatients with advanced cancer undergoing pallia-
tive care treatment, with knowledge of their diagnosis,
and who had given informed consent were eligible. Pa-
tients who were too ill to participate in interviews, and
non-native Spanish speakers were excluded. HCPs with
their main job in palliative care were eligible. For pa-
tients, the primary cancer site was registered, occupation
and years of experience were registered for HCPs, and
demographic characteristics were collected for all
participants.
Questionnaires
The Chilean-Spanish version of the QLQ-C30 question-
naire (version 3) was used for this study, and was ob-
tained from the EORTC Quality of Life Department in
Brussels. The QLQ-C30 consists of 30 items distributed
in five functional scales measuring physical, emotional,
role, cognitive and social functioning; three symptoms
scales measuring fatigue, pain, nausea/vomiting; one
scale measuring “global health and quality of life status”,
and six single items measuring sleeping difficulties, dys-
pnea, constipation, lack of appetite, financial difficulties,
and diarrhea. All items are rated on 4-points Likert
scales that range from 1 (not at all) to 4 (very much),
with the exception of the global health/quality of life
scale, which is rated from 1 (very poor) to 7 (excellent)
[25, 26].
The QLQ-C15-PAL is an abbreviated version of the
QLQ-C30, which was developed for patients in palliative
care preserving the main advantages of the original
questionnaire. The QLQ-C30 was shortened to 15 items
by omitting items of the QLQ-C30 that were considered
inappropriate or not highly relevant in palliative care by
patients and health care professionals in interviews, [3]
and by shortening multi-item scales of QLQ-C30 using
item response theory [4, 5]. Four scales, i.e., physical
functioning, emotional functioning, nausea/vomiting and
fatigue, were shortened retaining the items that best pre-
dicted scores on the original scales. Due to the low
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relevance reported in the interviews, the two-item global
QOL scale was reduced to one item by omitting overall
health, and five scales/items were completely omitted
(social, role and cognitive functioning scales, diarrhea
and financial difficulties items).
Procedure for interviews
To validate the content of the QLQ-C15-PAL question-
naire, we conducted semi-structured interviews follow-
ing the procedure originally used to develop a shortened
version of the QLQ-C30 for palliative care patients [3],
and the EORTC Quality of Life Group Guidelines for
developing questionnaire modules [27]. The purpose of
these interviews was to identify the most relevant issues
for patients in palliative care among those included in
the EORTC QLQ-C30 in order to investigate whether
the QLQ-C15-PAL also has the appropriate content for
use in Chile.
Patients were asked to respond to the Chilean-Spanish
version of the QLQ-C30 during individual interviews by
a trained researcher. The interviewer then invited pa-
tients to comment on how well the QLQ-C30 items
“evaluated the outcome of the palliative care they re-
ceived”. Patients were asked to comment on the QLQ-
C30 items in terms of relevance, appropriateness, rela-
tive importance, and breadth of coverage. The relevance
of each item was rated using the response categories 1
“not at all”, 2 “a little”, 3 “quite a bit” and 4 “very much”.
If an item was rated 1 or 2, patients were asked to report
the reasons, e.g., “Why do you consider this question
not or only a little relevant?”. The appropriateness was
measured asking patients to identify items they per-
ceived as inappropriate or upsetting. The relative im-
portance was evaluated asking patients to select the 10
most important items when evaluating the success of
palliative care. The breadth of coverage was assessed
asking patients to report additional issues that were rele-
vant for them but not covered by the QLQ-C30.
An identical interview was followed for HCPs, but they
were required to comment on how well the QLQ-C30
items “evaluated the outcome of palliative care in gen-
eral”, i.e., not for a specific patient, but for patients ad-
mitted to palliative care in general. HCPs were asked to
comment on relevance, appropriateness, relative import-
ance, and breadth of coverage of the QLQ-C30 items,
using the same procedure as described above.
Statistical analysis
Participants’ characteristics were expressed as propor-
tions for categorical variables, and as means, standard
deviations, medians and ranges for continuous vari-
ables. The mean relevance score of each item was cal-
culated after transforming the responses to 0–100
scales with 0 corresponding to “not at all” and 100 to
“very much” [26]. The proportion of participants rat-
ing each item as “inappropriate or upsetting” and
selecting each item as one of the 10 most important
were calculated. The proportion of participants who
selected at least one of the items from each multi-
item scale as one of the 10 most important was also
calculated. Single items and multi-item scales were
ranked according to the proportion of patients and
HCPs selecting them as among the 10 most import-
ant. This ranking named ‘importance percentage’ was
calculated as the average: (percentage of patients +
percentage of HCPs)/2; although the sample of pa-
tients was larger than HCP sample, both received
equal weight. Furthermore, this ranking was used to
compare the relative importance of the scales and
items as perceived by Chilean patients/HCPs with the
results of the original study [3]. HCPs were divided in
two subgroups, i.e., “physicians” and “other HCPs” to
explore differences between the rating of relevance
and importance for each dimension of the QLQ-C30,
tested by Mann-Whitney U Test. Qualitative data ob-
tained from the interviews were categorized into re-
sponses about the lack of relevance in selected items,
and the need to include other issues in the question-
naire, respectively. A p value < 0.05 was considered
statistically significant. Analyses were performed using
the statistical software Statistical Package for the So-
cial Sciences (SPSS) version 23.
Results
Participation
A total of 48 patients with advanced cancer and 35
HCPs participated in the interviews. The median age of
patients was 60 years, and the most common cancer
diagnoses were prostate cancer (14.6%), stomach cancer
(10.4%) and multiple myeloma (10.4%). HCPs had a me-
dian age of 39 years and the majority were physicians
(34.3%), followed by nurses (20.0%), and psychologists
(20.0%). For further details see Table 1.
Interviews
Relevance, appropriateness and relative importance of the
EORTC QLQ-C30
The quantitative data including ratings of relevance, in-
appropriateness, and relative importance of items are
summarized in Table 2, together with the qualitative
data from categorized responses to the question: “Why
do you consider this question not or only little relevant?”
presented in Table 3, will be discussed simultaneously
for each dimension of the QLQ-C30 questionnaire.
Scales and items are presented in the order in which
they appear in Tables 2 and 3, i.e., based on their im-
portance rating, where the 10 most important were pain,
physical functioning, sleeping difficulties, emotional
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functioning, nausea/vomiting, fatigue, social functioning,
lack of appetite, role functioning and constipation.
Pain (PA) scale Pain was selected as the most import-
ant dimension of the QLQ-C30 and both items were
rated as highly relevant.
Physical functioning (PF) scale The last item 5 “need
help with self-care” was rated as the most important
item of the scale, followed by item 4 “stay in bed”. Items
2 “long walk” and 3 “short walk” were rated as less rele-
vant by the respondents, who mentioned that these
questions regarding to walking limitations were not
Table 1 Characteristics of 48 patients and 35 health care professionals participating in interviews
Patient characteristics Patients Health care professionals
N (%) N (%)
Sex
Men 16 (33.3) 9 (25.7)
Women 32 (66.7) 26 (74.3)
Age
Mean (SD) 59.2 (13.1) 40.9 (12.7)
Median (range) 60 (29–86) 39 (23–70)
Hospitals
Sotero del Rio 27 (56.3) 12 (34.3)
San Juan de Dios 4 (8.3) 5 (14.3)
Salvador 13 (27.1) 11 (31.4)
Felix Bulnes Cerda 4 (8.3) 7 (20.0)
Diagnosis (cancer site, ICD-10)
Prostate (C61) 7 (14.6)
Stomach (C16) 5 (10.4)
Multiple myeloma (C90) 5 (10.4)
Breast (C50) 4 (8.3)
Colorectal (C18-C20) 3 (6.3)
Melanoma skin cancer (C43) 3 (6.3)
Uterine (C54-C55) 3 (6.3)
Ovarian (C56, C570-C574) 3 (6.3)
Liver (C22) 2 (4.2)
Sarcoma (C46-C49) 2 (4.2)
Cervical (C53) 2 (4.2)
Kidney (C64-C66) 2 (4.2)
Lymphoma (C81-C85) 2 (4.2)
Other cancer (all other C codes) 5 (10.4)
Discipline of HCPs
Physician 12 (34.3)
Nurse 7 (20.0)
Psychologist 7 (20.0)
Paramedic 6 (17.1)
Physiotherapist 1 (2.9)
Social worker 1 (2.9)
Nutritionist 1 (2.9)
Years of experience of HCPs
Mean (SD) 13.9 (11.9)
Median (range) 11 (1–42)
SD standard deviation, ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
Rojas-Concha et al. BMC Palliative Care           (2020) 19:81 Page 4 of 10
Table 2 Relevance, inappropriateness and importance of items reported by 48 patients and 35 health care professionals
Scale/item Item Relevance (mean) % Inappropriate % Selected as one of the most important
Pts. HCPs Pts. HCPs Pts. HCPs /2a
Pain (PA) 9 100 97 0 0 96 77
19 97 80 2 6 27 54
Any PA item 98 94 96
Physical functioning (PF) 1 77 64 6 9 40 3
2 78 63 2 0 25 3
3 76 73 4 3 17 9
4 83 85 6 3 23 51
5 98 95 0 0 60 71
Any PF item 98 80 89
Sleeping difficulties (SL) 11 97 95 0 0 75 86 80
Emotional functioning (EF) 21 95 63 0 3 19 6
22 93 68 0 2 21 11
23 92 73 0 0 21 17
24 98 89 0 0 38 60
Any EF item 73 83 78
Nausea and vomiting (NV) 14 96 88 0 0 25 54
15 97 87 0 0 35 46
Any NV item 46 69 57
Fatigue (FA) 10 97 67 2 3 50 6
12 92 73 0 3 31 20
18 92 74 2 3 42 14
Any FA item 77 34 56
Social functioning (SF) 26 93 89 2 3 31 54
27 88 83 4 0 8 31
Any SF item 38 60 49
Lack of appetite (AP) 13 99 86 0 0 35 57 46
Role functioning (RF) 6 95 79 0 0 50 23
7 82 57 2 6 31 6
Any RF item 60 26 43
Constipation (CO) 16 92 83 0 0 29 54 42
Financial difficulties (FI) 28 93 81 4 3 35 49 42
Global health status/ 29 97 90 0 0 8 23
Quality of life (QOL) 30 95 89 0 3 15 49
Any QL item 23 54 39
Dyspnea (DY) 8 70 70 2 3 46 17 31
Cognitive functioning (CF) 20 90 54 0 3 21 6
25 97 67 0 0 15 14
Any CF item 33 17 25
Diarrhea (DI) 17 93 79 2 0 17 20 18
The scales/items are ranked according to importance. Items in bold form were extracted from the EORTC QLQ-C30 to form the EORTC QLQ-C15-PAL questionnaire
a The mean of the values for patients (Pts.) and health care professionals (HCPs)
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appropriate for patients in palliative care. Item 1 “strenu-
ous activities” was the item most often rated as inappro-
priate by HCPs (9%).
Sleeping difficulties (SL) item Sleeping difficulties was
rated as very relevant and chosen as one of the most im-
portant dimensions by 80% of participants.
Emotional functioning (EF) scale The four items of
this scale were rated more relevant by patients than by
HCPs; however, 83% of HCPs compared to 73% of pa-
tients selected this scale as one of the 10 most important
for palliative care. Item 24 “feel depressed” was most
often selected as important particularly by HCPs. Nine
participants indicated that item 23 “feel irritable” was
poorly formulated, e.g., the word “irritable” could be re-
placed by “angry” (Table 3).
Nausea and vomiting (NV) scale Nausea and vomiting
were rated as highly relevant by respondents and se-
lected as two important items by 69% of the HCPs.
Fatigue (FA) scale More than a half of the patients se-
lected fatigue as an important dimension (77%) in com-
parison with the HCPs (34%). Item 12 “feel weak” was
the least important item selected by HCPs, mainly
Table 3 Categorized reasons why some items were rated as little or not relevant by the participants
Scale/item Item Relevancea Technical issuesb Inappropriatec Relatived Not importante Difficultf Total
Pts. HCPs Pts. HCPs Pts. HCPs Pts. HCPs Pts. HCPs Pts. HCPs
Pain 9 1 1
19 3 1 2 1 7
Physical functioning 1 5 5 3 3 1 17
2 4 6 1 1 1 1 1 1 16
3 4 6 1 2 1 1 1 1 17
4 3 2 1 1 1 8
5 –
Emotional functioning 21 1 5 1 2 1 1 1 1 13
22 1 5 2 1 1 1 1 12
23 1 4 5 1 1 12
24 2 3 1 6
Fatigue 10 5 1 1 1 1 1 10
12 3 2 3 1 2 1 12
18 1 4 1 1 2 1 10
Nausea and vomiting 14 1 2 2 5
15 2 1 3
Sleeping difficulties 11 1 1
Social functioning 26 1 1 1 1 1 5
27 1 2 2 1 2 8
Dyspnea 8 3 5 14 13 1 1 1 1 39
Role functioning 6 2 1 3 1 7
7 4 11 1 1 2 1 20
Constipation 16 1 10 7 18
Lack of appetite 13 1 1
Financial difficulties 28 1 2 1 2 1 1 8
Global health status/ 29 2 1 1 4
Quality of life 30 1 2 3 1 1 1 1 10
Cognitive functioning 20 4 11 1 1 4 21
25 1 8 1 1 11
Diarrhea 17 3 1 1 5
Total 36 96 39 56 15 17 18 3 5 14 4 4 307
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because they believed that this symptom was repeatedly
measured. HCPs found that item 10 “need to rest” was
the least important and less relevant of the scale.
Social functioning (SF) scale Social functioning scale
was selected as an important dimension by 49% of the
participants. Both items, item 26 “your physical condi-
tion or medical treatment has interfered with your fam-
ily life” and item 27 “your physical condition or medical
treatment has interfered with your social activities” were
scored with high relevance, especially item 26.
Lack of appetite (LA) item Lack of appetite was more
selected as an important item by HCPs than by patients
(57% vs. 35%).
Role functioning (RF) scale Role functioning scale was
very important for patients (60%), scoring with a high
relevance the item 6 “limitations at work or daily
activities”.
Constipation (CO) item Constipation was considered
by 42% of the respondents as an important item, and
about 20% (n = 17) of them suggested linguistic changes
for this question because it was difficult to understand
by patients (See also Table 4).
Financial difficulties (FI) item This item was chosen as
one of the most important by 49% of the HCPs com-
pared to 35% of the patients. Few participants described
this item as inappropriate for palliative care setting.
Global health status/ quality of life (QOL) scale Par-
ticipants rate both items as highly relevant. This dimen-
sion was selected as one of the most important more
often by the HCPs than by patients (54% vs. 23%), al-
though some respondents reported that item 30 as little
relevant because they believed the concept “quality of
life” is not understood by all patients in palliative care.
Dyspnea (DY) item Similar numbers of patients and
HCPs reported that dyspnea was a not well formulated
item making it difficult for patients to comprehend,
whereas 33% of participants (n = 27) suggested linguistic
changes for dyspnea (Table 4).
Cognitive functioning (CF) scale Cognitive functioning
was generally regarded as less important than the other
five functioning scales, selected only by 25% of respon-
dents. Item 20 “concentrating problems” was the least
relevant item in this scale.
Diarrhea (DI) item Although rated as relevant, diarrhea
was the issue least often selected as important.
The comparison of item relevance and importance
scores between physicians (n = 12) and other HCPs (n =
23) showed no significant differences; therefore, they are
not shown in Table 2.
Breadth of coverage of the EORTC QLQ-C30
Patients and HCPs were asked to report additional issues
that were not included in the QLQ-C30, which they
considered relevant for the outcome of the palliative
care. In total, 91 topics were mentioned by the respon-
dents. These were grouped into 10 overalls categories.
The three most frequent categories were satisfaction
with care, emotions and psychological support. Satisfac-
tion with care included topics about satisfaction of pa-
tients with HCPs, and effectiveness of medication,
mostly reported by patients. Emotions included topics
about role loss and mood changes, and psychological
support included phycological needs, and facing life with
advanced cancer. For further details see Table 5.
Discussion
In this study, we performed a content validation of the
QLQ-C15-PAL with 48 patients and 35 HCPs from four
palliative care services in Chile, replicating the method-
ology of a previous study conducted in six European
countries [3]. In general, our results were similar to that
study, confirming the content validity of the QLQ-C15-
PAL questionnaire, but we made important observations
that will be discussed later.
Of the 10 function/symptom scales included in the
QLQ-C15-PAL questionnaire, eight were selected
among the 10 most important dimensions to include in
Table 4 Categorized comments about linguistic issues found in
the dyspnea and constipation items of EORTC QLQ-C30
Scale/item Item Participant comments and
suggestions for alternative
wording
(quotation marks)
Pts. HCPs
Dyspnea 8 Not well formulated 1 2
“Ran out of air” 1 2
“Lack of air” 3 4
“Ran out of breath” 5 2
“Difficulty breathing” 2 1
“Maximum tiredness” 2
Did not understand “short of breath” 2
Total 14 13
Constipation 16 “Difficulty defecating” 3 6
“Troubles defecating” 2 1
“Bowel movements” 1 2
Did not understand “constipated” 1 1
Total 7 10
Pts Patients, HCPs health care professionals
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the assessment of palliative care in Chile, i.e., pain, phys-
ical functioning, sleeping difficulties, emotional function-
ing, nausea/vomiting, fatigue, lack of appetite and
constipation. Responses about the five shortened scales
from the original QLQ-C30 to form the QLQ-C15-PAL
were comparable to the Groenvold et al. study [3]. Phys-
ical functioning and fatigue scales were particularly im-
portant scales by patients, whereas emotional
functioning, nausea/vomiting and global health status/
QOL scales were essential for HCPs. Most of the items
of these scales that were finally retained in the QLQ-
C15-PAL, were also selected by our respondents as rele-
vant issues to measure the outcome of palliative care.
The most important dimension selected by the partici-
pants was pain (96%), which has been recognized in the
literature as one of the most prevalent symptoms re-
ported by advanced cancer patients in palliative care [28,
29]. Other dimensions frequently selected as important
were physical functioning (89%), sleeping difficulties
(80%), emotional functioning (78%), nausea/vomiting
(57%), fatigue (56%) and social functioning (49%). These
dimensions were previously identified as prevalent pallia-
tive needs in a study investigating the content validity of
PROs instruments in palliative care, by comparing pa-
tient reported symptoms and problems to what was reg-
istered in the medical records [30]. Although social and
role functioning were excluded in the development of
the QLQ-C15-PAL due to the lack relevance reported in
the original study [3], in our study these dimensions
were selected as the most important by 49 and 43% of
respondents respectively, principally HCPs selected so-
cial functioning in relation to family life of patients, and
patients selected role functioning in relation to their lim-
itations at work. Patients’ concern about their role in the
family, the social support they received from family, and
personal challenges related to work have been reported
before by a palliative care service in a small qualitative
study conducted in Chile [31].
Qualitative data corresponding to additional issues not
covered by the questionnaire showed that HCPs re-
ported twice as many topics as patients did. A reason
may be that HCPs have the perspective of many patients
while patients focus on their own situation. Further, the
breadth of coverage question was asked at the end of the
interview, hence, some patients may have been too fa-
tigued to give comprehensive responses. The main add-
itional issues reported in our study were satisfaction
with care, emotions and psychological support. In con-
trast, additional issues related with existential and spirit-
ual issues were frequently reported by Groenvold et al.
[3]. Further research is needed to evaluate which aspects
not covered by the QLQ-C15-PAL may be relevant for a
comprehensive measurement of the QOL in Chilean pal-
liative care patients, e.g., a social dimension. While social
support for patients in palliative care and their families
has been recommended by the Chilean Ministry of
Health [32], as well as international organizations [1,
33], social needs do not seem to be covered by current
palliative care in Chile, as only one of the four palliative
care services in this study had a social worker in their
teams.
The qualitative data was useful to identify unex-
pected linguistics issues in the dyspnea and constipa-
tion items, since 33 and 20% of the participants
reported that these questions were not well formu-
lated or were difficult to understand. A list with the
comments about these two items was submitted to
the Translation Unit of the EORTC Quality of Life
Department for possible revision of the translation of
these items. After their analysis both items were
modified in the Chilean versions of the QLQ-C30,
and the QLQ-C15-PAL questionnaires.
Table 5 Additional issues that would be relevant to include
when evaluating the outcome of palliative care
Additional issues categories Pts. HCPs
Satisfaction with care 8 4
Satisfaction with health care professionals, satisfaction with
the information received, adherence to treatment,
effectiveness of medication and side effects
Emotions 5 7
Role loss, mood changes, sadness, anhedonia, fear
Psychological support 6 6
Psychological needs, significant changes to the way of
living, facing life with advanced cancer, measure
psychological distress, personality disorders
Sexuality 1 10
Sexual satisfaction, sexual activity
Social support 4 5
Support from family/relatives, caregivers’ distress,
cohabitation, e.g., whom do you live with?
Symptoms and problems 2 7
Visual problems, sleeping tongue, eating/swallowing
problems, drowsiness, dementia/delirium, urinary problems
Existential issues 1 8
Thoughts about death, uncertainty about future,
transcendence
Spiritual issues 6
Spiritual pain, spirituality
Physical difficulties 3 3
Ability to move around on you own at home, toileting
independence
Economic problems 1 4
Delay in sick leave payment, transportation expenses, e.g.,
go to hospital
Total number of issues 31 60
Pts Patients, HCPs health care professionals
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We recognize some limitations related to this study.
First, we did not evaluate statistically the psychometric
properties of the QLQ-C15-PAL in Chilean patients;
however, it has been extensively validated in previous
international studies [6–13]. Second, we planned to re-
cruit at least 10 HCPs from each palliative care service,
but half of the services investigated had less than 10 pro-
fessionals in their teams. Nevertheless, we had no miss-
ing data for the study analysis, since the participants
were accompanied by the researcher during their self-
assessment of the QLQ-C30 or were assisted if
necessary.
Conclusions
The EORTC QLQ-C15-PAL showed good content valid-
ity in the assessment of symptoms and QOL of advanced
cancer patients. Additionally, we identified linguistic is-
sues in the dyspnea and constipation items that were re-
vised by the EORTC group. This questionnaire may help
clinicians, and researchers to initiate palliative care inter-
ventions that may improve QOL of patients. Therefore,
we recommend the use of the EORTC QLQ-C15-PAL
in patients receiving palliative care in Chile. More re-
search is needed to add a social dimension for a compre-
hensive assessment of patients’ QOL in Chile.
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